FDA Approved: DIAZEPAM — Supplemental Application (Natco Pharma USA LLC)

View source ↗

Summary

The FDA approved a supplemental application for Diazepam from Natco Pharma USA LLC, granting approval of generic diazepam under ANDA210363.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Anxiety Disorders
• Epilepsy
• Muscle Spasticity

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)